Mylan Inc. (MYL: Quote) said its subsidiary Mylan Pharmaceuticals Inc. has launched Desloratadine Tablets, 5 mg, the generic version of Schering-Plough's Clarinex allergy medication.
Earlier, Mylan obtained final approval from the U.S. Food and Drug Administration, or FDA, for its Abbreviated New Drug Application for Desloratadine Tablets, 5 mg, and is shipping this product immediately.
According to IMS Health, Desloratadine Tablets, 5 mg, had U.S. sales of around $194.6 million for the 12 months ending March 31, 2012.
Click here to receive FREE breaking news email alerts for Mylan Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org